Informação sobre produto
- (2S,4R)-4-(phosphonomethyl)piperidine-2-carboxylic acid
- 2-Piperidinecarboxylic acid, 4-(phosphonomethyl)-, (2R,4S)-rel-
- 2-Piperidinecarboxylic acid, 4-(phosphonomethyl)-, cis-
- Cgs 19755
- Cpdd 0027
- Selfotel [USAN:INN]
- cis-4-(Phosphonomethyl)pipecolic acid
- cis-4-[Phosphonomethyl]-2-piperidinecarboxylic acid
- rel-(2R,4S)-4-(Phosphonomethyl)-2-piperidinecarboxylic acid
- Selfotel
- Ver mais sinónimos
CGS 19755 is a low-potency compound that has been investigated for its potential use in the treatment of neurodegenerative diseases. It is a selective, non-competitive antagonist of the metabotropic glutamate receptor type 2 (mGluR2) which has shown to reduce neuronal death and improve motor function in experimental models. CGS 19755 has also been shown to have no significant side-effect profiles in humans and has been tested as a pharmacological agent for the treatment of Parkinson's disease. The major analytical method used to measure the potency of CGS 19755 is intracellular Ca2+ levels.
Propriedades químicas
Consulta técnica sobre: 3D-KEA34785 CGS 19755
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
